CP-481715

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameCP-481715
Drug Alias NameCP-481715
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 1 antagonists
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsDermatitis, Allergic Contact
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, Allergic Contact

Other Information

ATC CodeN/A
Related LinksN/A